Year of Publicationsort descending Title Faculty Association
2013 Truncation of the peptide sequence in bifunctional ligands with mu and delta opioid receptor agonist and neurokinin 1 receptor antagonist activities. Victor Hruby, Ph.D., Josephine Lai , Ph.D., Tally Largent-Milnes, PhD, Edita Navratilova, Frank Porreca, PhD, Todd Vanderah, PhD
2013 Potentiation of brain mitochondrial function by S-equol and R/S-equol estrogen receptor β-selective phytoSERM treatments. Roberta Diaz Brinton, Ph.D
2013 Cancer-induced bone pain: Mechanisms and models. Todd Vanderah, PhD
2013 Window of opportunity for estrogen and progestin intervention in brain aging and Alzheimer's disease. Roberta Diaz Brinton, Ph.D
2014 Neuropathic plasticity in the opioid and non-opioid actions of dynorphin A fragments and their interactions with bradykinin B2 receptors on neuronal activity in the rat spinal cord. Frank Porreca, PhD
2014 Reversal of metabolic deficits by lipoic acid in a triple transgenic mouse model of Alzheimer's disease: a 13C NMR study. Roberta Diaz Brinton, Ph.D
2014 Src-mediated post-translational regulation of endoglin stability and function is critical for angiogenesis. Nam Lee, Ph.D.
2014 Three-dimensional printing surgical instruments: are we there yet?
2014 Physiological temperatures drive glutamate release onto trigeminal superficial dorsal horn neurons. Tally Largent-Milnes, PhD
2014 Differential neuroprotective potential of CRMP2 peptide aptamers conjugated to cationic, hydrophobic, and amphipathic cell penetrating peptides.
2014 Structure-activity relationships of non-opioid [des-Arg(7)]-dynorphin A analogues for bradykinin receptors. Frank Porreca, PhD
2014 Hypermetabolic state in the 7-month-old triple transgenic mouse model of Alzheimer's disease and the effect of lipoic acid: a 13C-NMR study. Roberta Diaz Brinton, Ph.D
2014 Capsaicin-responsive corneal afferents do not contain TRPV1 at their central terminals in trigeminal nucleus caudalis in rats. Tally Largent-Milnes, PhD
2014 Discovery of amphipathic dynorphin A analogues to inhibit the neuroexcitatory effects of dynorphin A through bradykinin receptors in the spinal cord. Victor Hruby, Ph.D., Josephine Lai , Ph.D., Frank Porreca, PhD, Todd Vanderah, PhD
2014 Synthesis and evaluation of bivalent ligands for binding to the human melanocortin-4 receptor.
2014 External QX-314 inhibits evoked cranial primary afferent synaptic transmission independent of TRPV1. Tally Largent-Milnes, PhD
2014 Animal models for opioid addiction drug discovery. Tally Largent-Milnes, PhD, Todd Vanderah, PhD
2014 Behavioral and cellular pharmacology characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan (NAQ) as a mu opioid receptor selective ligand. John M. Streicher, PhD
2014 Frontiers in therapeutic development of allopregnanolone for Alzheimer's disease and other neurological disorders. Roberta Diaz Brinton, Ph.D
2014 Drug delivery to the ischemic brain. Patrick T Ronaldson, PhD, FAAPS
2014 Immortalization of normal human mammary epithelial cells in two steps by direct targeting of senescence barriers does not require gross genomic alterations.
2014 Differential regulation of collapsin response mediator protein 2 (CRMP2) phosphorylation by GSK3ß and CDK5 following traumatic brain injury.
2014 Intranasal drug delivery to the brain Jeffrey J. Lochhead, PhD
2014 Estrogen: a master regulator of bioenergetic systems in the brain and body. Roberta Diaz Brinton, Ph.D
2014 Hypoxia/reoxygenation stress signals an increase in organic anion transporting polypeptide 1a4 (Oatp1a4) at the blood-brain barrier: relevance to CNS drug delivery. Patrick T Ronaldson, PhD, FAAPS